Skip to content
Home/Companies/Biotech/GenePlanet

GenePlanet

Biotech·Slovenia·Active·New
Entry
2026
Hold
New
Status
Active

Who owns GenePlanet?

GenePlanet is a Biotech company based in Slovenia, currently owned by Lauxera Capital Partners since 2026.

Hand-verified · updated 2026-08-19

Open JSON · CC-BY
Lauxera Capital Partners
Investor
Lauxera Capital Partners
Lauxera Growth II · 2025 · Growth

Key facts

HQSlovenia
SectorBiotech
StatusActive

More from Lauxera Growth II

Other portfolio companies in the same fund.

Bridge to Life
Active
MedTechUS· 2026
Antaros Medical
Antaros Medical
Active
BiotechSweden· 2025
Acandis
Acandis
Active
MedTechGermany· 2024

More Lauxera Capital Partners portfolio companies

From the same investor, across funds.

Natural Cycles
Natural Cycles
Active
HealthTechSweden· 2024
Ospi
Ospi
Active
HealthTechFrance· 2024
BioLamina
BioLamina
Active
BiotechSweden· 2023
Caresyntax
Active
HealthTechGermany· 2023
Matrix One
Matrix One
Active
HealthTechGermany· 2023
Reapplix
Reapplix
Active
MedTechDenmark· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns GenePlanet?

GenePlanet is currently owned by Lauxera Capital Partners, through Lauxera Growth II, since 2026.

When did Lauxera Capital Partners acquire GenePlanet?

Lauxera Capital Partners acquired GenePlanet in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue